|
Volumn 22, Issue 2, 2003, Pages 345-351
|
Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD40 LIGAND;
COMPLEMENTARY DNA;
FLT3 LIGAND PROTEIN;
HYBRID PROTEIN;
MEMBRANE PROTEIN;
ANIMAL;
ARTICLE;
C3H MOUSE;
CANCER TRANSPLANTATION;
CELL CULTURE;
DEFECTIVE VIRUS;
EVALUATION;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HELA CELL;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
INNATE IMMUNITY;
LIVER TUMOR;
MASTADENOVIRUS;
MOUSE;
NATURAL KILLER CELL;
NUDE MOUSE;
PATHOLOGY;
PHYSIOLOGY;
SUBCUTANEOUS DRUG ADMINISTRATION;
TRANSPLANTATION;
ANIMALS;
CD40 LIGAND;
DEFECTIVE VIRUSES;
DNA, COMPLEMENTARY;
GENE THERAPY;
GENETIC VECTORS;
HELA CELLS;
HUMANS;
IMMUNITY, NATURAL;
IMMUNOTHERAPY;
INJECTIONS, SUBCUTANEOUS;
KILLER CELLS, NATURAL;
LIVER NEOPLASMS, EXPERIMENTAL;
MASTADENOVIRUS;
MEMBRANE PROTEINS;
MICE;
MICE, INBRED C3H;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
RECOMBINANT FUSION PROTEINS;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
EID: 0042161923
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.22.2.345 Document Type: Article |
Times cited : (10)
|
References (0)
|